Pain Medicine Pallitiave Care is categorized under Hospitals in New York City, NY .
Pain Medicine Pallitiave Care was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Russell Portenoy, Office Manager at the company’s single location by writing to 350 East 17th St, New York City, New York NY 10003 or by phoning (212) 844-1505. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pain Medicine Pallitiave Care |
| Contact Person: | Russell Portenoy, Office Manager |
| Address: | 350 East 17th St, New York City, New York 10003 |
| Phone Number: | (212) 844-1505 |
| Website Address: | bimc.org |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hospitals |
| SIC Code: | 8062 |
| NAICS Code: | 6211110 |
| Share This Business: |
Pain Medicine Pallitiave Care was started in 0 to provide professional Hospitals under the SIC code 8062 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Russell Portenoy, Office Manager for inquiries that concern Pain Medicine Pallitiave Care by calling the company number (212) 844-1505, as your correspondence is most welcome. Additionally, the physical location of the single location of Pain Medicine Pallitiave Care can be found at the coordinates 40.7333,-73.9814 as well as the street address 350 East 17th St in New York City, New York 10003.
For its online presence, you may visit Pain Medicine Pallitiave Care’s website at bimc.org and engage with its social media outlets through on Twitter and on Facebook.